Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rachel P Mojdehbakhsh"'
Publikováno v:
Gynecologic Oncology Reports, Vol 36, Iss , Pp 100708- (2021)
The primary goal was to convert 50% of all outpatient Gynecologic Oncology (GynOnc) encounters during the COVID-19 pandemic to telemedicine within one week. The secondary goal was to reach 100% documentation of telemedicine consent. The tertiary goal
Externí odkaz:
https://doaj.org/article/ab8c1a51dad342b08963a587fcffd569
Publikováno v:
Gynecologic Oncology Reports, Vol 43, Iss , Pp 101059- (2022)
Objectives: This study sought to compare differences in blood transfusion and surgical complication rates before and after the implementation of a restrictive blood transfusion protocol. Methods: On July 1, 2018, our institution implemented a restric
Externí odkaz:
https://doaj.org/article/3deb9da58084434dbdb571772a1a27b3
Autor:
Rachel P. Mojdehbakhsh, Arielle C. Mora Hurtado, Shitanshu Uppal, Hailey Milakovich, Ryan J. Spencer
Publikováno v:
Gynecologic Oncology Reports, Vol 42, Iss , Pp 101037- (2022)
Objective: The primary aim of this study was to evaluate gynecologic cancer patients’ satisfaction with telemedicine visits over a one-year period during the COVID-19 pandemic. The secondary aim was to characterize how gynecologic cancer recurrence
Externí odkaz:
https://doaj.org/article/3ef8605519a44630af3212c46fc769a5
Publikováno v:
Gynecologic oncology. 165(1)
Disparities persist in the enrollment of racial/ethnic groups in clinical trials for ovarian cancers. We sought to analyze the enrollment rates of patients by race/ethnicity in phase II/III clinical trials involving poly(ADP-ribose) polymerase (PARP)
Publikováno v:
Gynecologic Oncology. 162:S64-S65
Objectives: Disparities persist in the enrollment of diverse racial and ethnic groups in clinical trials for ovarian and breast cancers. We sought to analyze the enrollment of participants by race/ethnicity in phase II and III clinical trials involvi
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 36, Iss, Pp 100708-(2021)
Gynecologic Oncology Reports, Vol 36, Iss, Pp 100708-(2021)
The primary goal was to convert 50% of all outpatient Gynecologic Oncology (GynOnc) encounters during the COVID-19 pandemic to telemedicine within one week. The secondary goal was to reach 100% documentation of telemedicine consent. The tertiary goal